Number of Credits
Price
Author
Cynthia Cardelino, MLT(ASCP), MT(HEW)
This course provides CME credit and is only for individuals that are eligible for CME credit (physicians, nurse practitioners, nurses). All others should register for the course under the Laboratory Training category where the course is offered for
P.A.C.E. credit.
This course has been designed to meet the needs of physicians operating an office laboratory; healthcare professionals working as medical laboratory staff in nonwaived diagnostic laboratories, including testing personnel, technical consultants, supervisors, and laboratory directors.
Competency Assessment has recently been subject to increased regulatory emphasis. The competency assessment requirements are not new, but there is a stronger focus on compliance because of the significant impact that laboratory personnel have on patient care. Competency assessment is required by CLIA and accrediting agencies, and is an important tool to reduce laboratory errors. Competency Assessment is the means to confirm that the training provided was effective and that personnel are capable of following established procedures in the pre-analytic, analytic and post-analytic phases to accurately perform laboratory testing that produces quality results.
The laboratory director is responsible for establishing policies and procedures for competency assessment. This course will assist you with developing and implementing a competency assessment program that is meaningful, ensures the technical competency of your staff, and meets the requirements.
Learning Objectives
- Differentiate between Training, Personnel Evaluations and Competency Assessment
- Outline the regulatory requirements for competency assessment
- Develop procedures to effectively incorporate the six required methods for competency assessment
- Perform and document meaningful and compliant competency assessments
This course will take 1.5 hours to complete and there are no prerequisites. A credit certificate will be issued upon completion of the course evaluation and post-test with a score of 80% or better.
This CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care, practice-based learning and systems-based practice.
The AAFP has reviewed Laboratory Director CME Program, and deemed it acceptable for AAFP credit. Term of approval is from 10/01/2021 to 10/01/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s):
- 1.50 Enduring Materials, Self-Study AAFP Elective Credit(s) – Competency Assessment
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
- Outline
- Introduction
- Regulatory Requirements
- Personnel Training
- Competency Assessment Basics
- Procedures for Assessing Testing Personnel
- PPMP Certificate Labs
- Consultants and Supervisors
- Review and Tips for Success
- Resources & References
- Graded Exam
Free, current version of Internet Explorer, Chrome, Firefox, or Safari. (Some older browsers could produce error messages or not display the content correctly.)
Free, current version of Adobe Reader.
It is the policy of the AAFP and LabUniversity that the faculty, authors, planners, and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests* in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:
Author and Course Reviewer: Cynthia Cardelino, MLT(ASCP), MT(HEW)
No relevant financial relationships to disclose, No discussion of unlabeled/unapproved uses of drugs/devices during presentation.
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.